Want to Calculate Fair Value?
Enter Stock | Calculate Fair Value

Stock: AMED
Book Value Per Share: $36.55
EPS: $4.59
Diluted EPS TTM: $2.71
Dividend Per Share: None
Dividend Yield: 0.00 %
Dividend Payout Ratio: 0%
Price To Sales Ratio TTM: 1.345
Price To Book Ratio: 2.658
PEG Ratio: 1.413
EV To EBITDA: 13.96
P/E Ratio: 35.85
Forward P/E Ratio: 21.19
Ex Dividend Date: None
Dividend Date: None
Current Price: $97.46
Previous Close: $97.89
52 Week Low: $82.15
52 Week High: $98.95
Earning Date (within 30 days): N/A
50 Day MA: $94.04
200 Day MA: $93.15
Link to Yahoo (Financial): AMED

Advertisement
 
* Note: Prices are in Million (M) USD.
Description:
Amedisys Inc (AMED) â–¼
Amedisys, Inc., provides healthcare services in the United States. The company is headquartered in Baton Rouge, Louisiana.
These criteria used Company’s Cash, EBITDA and Debt balance to determines its fair value:
Cash : $303 M
Debt : $339 M
EBITDA : $244 M
Net Debt (Debt - Cash): $36 M

Since Net Debt is covered by EBITDA within 1 year, 3 points assigned.
This criteria used industry in which company operates:
Sector: Healthcare
Industry: Medical Care

Based on industry, 3 points assigned.
This criteria used Company’s Price To Earning (P/E) Ratio to determines its fair value:
Forward PE Ratio: 21.23

Since Forward PE Ratio is between 20 - 25, 2 points assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Average Free Cash Flow: $188 M
Average Revenue: $1,517 M
Revenue Converted To Free Cash FLow(%): 12 %
Avg Free Cash Flow Growth Per Year (Last 5 Years): 10.22%

Since Free Cash Flow (FCF) to Revenue percentage is less than 15, 1 point assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2024-12-31): $2,348 M
Revenue 4 Years Ago (2020-12-31): $2,072 M
Last 5 Years Average Revenue Growth: 3%

Since Revenue Growth is between 0 - 5, 1 point assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2024-12-31): $33 M
Share Count 5 Years Ago (2020-12-31): $33 M

Company is buying back its own shares, 3 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Earnings Per Share (EPS): $4.59
Dividend Per Share (DPS): $0
Payout Ratio: 0%
Dividend Yield: 0%

Since Dividend Per Share is less than or equal to 0, 0 point assigned.

Since Dividend Yield is less than 1, 0 point assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Average ROE: 4%

Since Average ROE is less than 10, 1 point assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $97
52-Week Low: $82
Threshold Price (15% Above 52-Week Low): $94

Since Current price is not within 15% threshold, 0 point assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $3,189 M

Since Market Cap is less than 10B, 1 point assigned.
% Exposure to Total Portfolio
Based on the calculated score, we recommend do not exceed 2% exposure of Total Portfolio.
Value-Trade has assigned 15 points to above Amedisys Inc (AMED) stock.